Australian Cannabis Biotech Up 271%

Analysis originally distributed on August 30, 2017 By: Michael Vodicka of Cannabis Stock Trades

Opioid abuse has quickly grown into a major global epidemic.

While opioids can be great for pain relief, the down side is that they are highly addictive. Recent data shows that opioid abuse and addiction is killing tens of thousands of people every year in just the United States.

Overdose deaths caused by prescription opioids have quadrupled since 1999. From 1999 to 2015, more than 183,000 people have died in the U.S. from overdoses related to prescription opioids.

This is an alarming trend that has both patients and health care professionals asking - are we capable of providing a better alternative?

According to a young biotech located Australia the answer is yes - and the solution comes in the form of cannabis.

If this young cannabis biotech is correct, not only will patients benefit, early shareholders will be rewarded with huge gains.

Let's take a look. Continue reading "Australian Cannabis Biotech Up 271%"

4 Cannabis Stocks With The Best Chance To Be The Next Starbucks

Analysis originally distributed on December 14, 2016 By: Michael Vodicka of Cannabis Stock Trades

Back in 1991, very few people had heard of a company called Starbucks.

After all, what kind of fool would pay more than $2 for a cup of coffee? Particularly when you could brew a cup at home.

Today, Starbucks is a billion-dollar global leader and one of the most recognized consumer brands in the world. Early investors have been rewarded with life-changing gains.

Shares are up almost 17,000% in the last 25 years. Investing $10,000 at the IPO in 1991 would be worth $1.7 million today. $25,000 would have grown into $4.4 million. Take a look at the big gains below. Continue reading "4 Cannabis Stocks With The Best Chance To Be The Next Starbucks"